Literature DB >> 20592228

Defective myogenic response to posture change in retinal vessels of well-controlled type 1 diabetic patients with no retinopathy.

Mara Lorenzi1, Gilbert T Feke, Linda Pitler, Fatmire Berisha, Julia Kolodjaschna, J Wallace McMeel.   

Abstract

PURPOSE: The current approach to the prevention of diabetic retinopathy relies on intensive anti-diabetes treatment and is only partially successful. A marker of retinopathy risk would enable strategies of surveillance, screening of adjunct drugs, and targeted drug interventions. The authors sought to identify early abnormalities of retinal vessels that are not prevented by the current therapeutic approach.
METHODS: Retinal thickness (an informer of vascular permeability) and hemodynamic parameters at baseline and longitudinally were measured in 27 subjects (age, 32 ± 9 years [mean ± SD]) with well-controlled type 1 diabetes of 12.4 ± 6.4 years' duration and no retinopathy, and in 27 control subjects. In a subset of 17 patients and 11 controls, the hemodynamic response to reclining, a postural change that increases retinal perfusion pressure, was measured.
RESULTS: Baseline foveal thickness and hemodynamic parameters were similar in the diabetic and control subjects. Foveal thickness increased over 12 months in the diabetic subjects, from 217 ± 22 μm to 222 ± 20 μm (P = 0.0036), remaining however within the normal range. Reclining uncovered in 47% of diabetic subjects (P = 0.016 compared with controls) an absent myogenic response (i.e., unchanged or increased arterial diameter instead of the normal decrease). The patterns were repeatable. Only the diabetic group with defective vasoconstriction showed widening arterial diameter over 12 months, a change presaging vascular dilatation in diabetic retinopathy.
CONCLUSIONS: Defective myogenic response to pressure was the first detectable abnormality of retinal vessels in subjects with well-controlled type 1 diabetes. Because of its selective occurrence, interpretability in individual patients, and pathogenic potential, the abnormality deserves evaluation as a risk marker for retinopathy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20592228     DOI: 10.1167/iovs.10-5785

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  Inhibition of 20-HETE attenuates diabetes-induced decreases in retinal hemodynamics.

Authors:  Zhongli Wang; Amit Singh Yadav; Wendy Leskova; Norman R Harris
Journal:  Exp Eye Res       Date:  2011-05-30       Impact factor: 3.467

Review 2.  Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markers.

Authors:  Timothy J Lyons; Arpita Basu
Journal:  Transl Res       Date:  2012-01-31       Impact factor: 7.012

3.  Acute Hyperglycemia Reverses Neurovascular Coupling During Dark to Light Adaptation in Healthy Subjects on Optical Coherence Tomography Angiography.

Authors:  Changyow C Kwan; Hee Eun Lee; Gregory Schwartz; Amani A Fawzi
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-04-09       Impact factor: 4.799

Review 4.  Emerging understanding of roles for arterioles in inflammation.

Authors:  Ronen Sumagin; Ingrid H Sarelius
Journal:  Microcirculation       Date:  2013-11       Impact factor: 2.628

5.  Earliest Evidence of Preclinical Diabetic Retinopathy Revealed Using Optical Coherence Tomography Angiography Perfused Capillary Density.

Authors:  Richard B Rosen; Jorge S Andrade Romo; Brian D Krawitz; Shelley Mo; Amani A Fawzi; Rachel E Linderman; Joseph Carroll; Alexander Pinhas; Toco Y P Chui
Journal:  Am J Ophthalmol       Date:  2019-01-26       Impact factor: 5.258

Review 6.  MRI of rod cell compartment-specific function in disease and treatment in vivo.

Authors:  Bruce A Berkowitz; David Bissig; Robin Roberts
Journal:  Prog Retin Eye Res       Date:  2015-09-04       Impact factor: 21.198

Review 7.  MRI biomarkers for evaluation of treatment efficacy in preclinical diabetic retinopathy.

Authors:  Bruce A Berkowitz; David Bissig; Oliver Dutczak; Shannon Corbett; Rob North; Robin Roberts
Journal:  Expert Opin Med Diagn       Date:  2013-06-21

Review 8.  Retinal vascular caliber as a biomarker for diabetes microvascular complications.

Authors:  M Kamran Ikram; Carol Y Cheung; Mara Lorenzi; Ronald Klein; Teresa L Z Jones; Tien Yin Wong
Journal:  Diabetes Care       Date:  2013-03       Impact factor: 19.112

9.  Corneal confocal microscopy detects neuropathy in patients with type 1 diabetes without retinopathy or microalbuminuria.

Authors:  Ioannis N Petropoulos; Patrick Green; Agnes W S Chan; Uazman Alam; Hassan Fadavi; Andrew Marshall; Omar Asghar; Nathan Efron; Mitra Tavakoli; Rayaz A Malik
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.